Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Massachusetts Life Sciences Center

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 119
Average round size
info
The average size of a deal this fund participated in
$997K
Portfolio companies 102
Rounds per year 7.44
Lead investments 11
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.14
Exits 5
Key employees Soon
Stages of investment
Early Stage Venture

Areas of investment

  • Health Care
  • Biotechnology
  • Medical
  • Education
  • Medical Device
Summary

In 2006 was created Massachusetts Life Sciences Center, which is appeared as Corporate Investor. The leading representative office of defined Corporate Investor is situated in the Waltham. The venture was found in North America in United States.

The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 4 of the founder, the chance for it to be financed is low. We can highlight the next thriving fund investment areas, such as Medical, Genetics. Among the various public portfolio startups of the fund, we may underline Candel, Massachusetts Biomedical Initiatives, Baystate Health For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of more than 20 years to get the investment from the fund.

The real fund results show that this Corporate Investor is 30 percentage points more often commits exit comparing to other companies. Opposing the other organizations, this Massachusetts Life Sciences Center works on 17 percentage points less the average amount of lead investments. Deals in the range of 1 - 5 millions dollars are the general things for fund. The high activity for fund was in 2019. The fund is constantly included in 2-6 investment rounds annually. The top amount of exits for fund were in 2016.

The typical case for the fund is to invest in rounds with 1-2 participants. Despite the Massachusetts Life Sciences Center, startups are often financed by National Institutes of Health, MassChallenge, National Science Foundation. The meaningful sponsors for the fund in investment in the same round are MassChallenge, Center for the Advancement of Science in Space. In the next rounds fund is usually obtained by National Science Foundation, National Institutes of Health, Massachusetts Office of International Trade and Investment (MOITI).

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Massachusetts Life Sciences Center:
Typical Co-investors
Massachusetts Life Sciences Center is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Massachusetts Life Sciences Center:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
757 Angels Norfolk, United States, Virginia
Cardiovascular Systems Minnesota, Saint Paul, United States
Gridsum Holding -
Redhawk Ventures Ohio, Oxford, United States
Sparkasse Bank Makedonija North Macedonia, Skopje, Skopje Region
Taubman Centers Inc. Bloomfield Hills, Michigan, United States
Tenderloin Ventures Switzerland, Zug, Zug
Thawer Capital Management (UK) England, London, United Kingdom

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

AcousticaBio

$50K09 Apr 2021 Cambridge, Massachusetts, United States

ImmuneXcite

Biotechnology
Drug Discovery
Health Care
Medical
Pharmaceuticals
$3M07 Jan 2014 Massachusetts, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Massachusetts Life Sciences Center?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 119
Average round size 997K
Rounds per year 7.44
Peak activity year 2019
Lead investments 11
Follow on index 0.14
Exits 5
Group Appearance index 0.08

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

AcousticaBio

$50K09 Apr 2021 Cambridge, Massachusetts, United States

ImmuneXcite

Biotechnology
Drug Discovery
Health Care
Medical
Pharmaceuticals
$3M07 Jan 2014 Massachusetts, United States
Crunchbase icon

Content report

The following text will be sent to our editors: